Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinicopathologic conference: Barth Syndrome.

James C Huhta1, Herbert H Pomerance, Enid Gilbert Barness

  • 1University of South Florida College of Medicine, Tampa, 33606, USA.

Fetal and Pediatric Pathology
|January 7, 2006
PubMed
Summary

This case study details Barth Syndrome, a rare genetic disorder. Diagnosis involves clinical and pathological findings, with elevated 3-methylglutaconic acid (3MGC) as a key indicator.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoplastic Left Heart Syndrome: Is There a Role for Fetal Therapy?

Frontiers in pediatrics·2022
Same author

First-trimester screening for congenital heart disease.

Current opinion in cardiology·2015
Same author

Summary of the 2015 International Paediatric Heart Failure Summit of Johns Hopkins All Children's Heart Institute.

Cardiology in the young·2015
Same author

Diagnosis and treatment of foetal heart failure: foetal echocardiography and foetal hydrops.

Cardiology in the young·2015
Same author

Variation in Prenatal Diagnosis of Congenital Heart Disease in Infants.

Pediatrics·2015
Same author

Dynamics of pulmonary venous flow in fetuses with intrauterine growth restriction.

Prenatal diagnosis·2014

Area of Science:

  • Biochemistry
  • Genetics
  • Pathology

Background:

  • Barth Syndrome is a rare X-linked genetic disorder.
  • It affects multiple organ systems, primarily the heart and skeletal muscles.
  • Understanding the etiology is crucial for diagnosis and management.

Observation:

  • Presents a clinico-pathologic case conference of Barth Syndrome.
  • Highlights the collaborative diagnostic approach between clinicians and pathologists.
  • Emphasizes the importance of detailed clinical and pathological examination.

Findings:

  • Discusses the current understanding of Barth Syndrome etiology.
  • Identifies elevated 3-methylglutaconic acid (3MGC) as a significant biochemical marker.
  • Correlates clinical manifestations with pathological findings.

Implications:

  • Enhances diagnostic accuracy for Barth Syndrome.
  • Provides insights into the metabolic disturbances associated with the condition.
  • Contributes to the collective knowledge base for managing rare genetic disorders.

Related Experiment Videos